Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel with or without Valspodar in Advanced Breast Cancer
NCT00002937Phase 2Completed
- Sponsor
- City of Hope
- Start
- Jun 1996
- Primary completion
- Nov 2005
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of valspodar in breast cancer, sponsored by City of Hope. Started Jun 1996; status: completed.
02
Drugs
valspodar
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00002937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002937.